MedTrace Logo

Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and Dysglycemia

NCT04456712 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-07-02

No results posted yet for this study

Summary

To compare intravenous levofloxacin and ciprofloxacin regarding their risk on the corrected QT interval (QTc) prolongation and dysglycemia in diabetic and non-diabetic patients.

Conditions

  • QTc Prolongation, Hyperglycemia, Hypoglycemia

Interventions

DRUG

Ciprofloxacin 400 MG/200 ML Intravenous Solution

antibiotic

DRUG

Levofloxacin 750 MG

antibiotic

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Ahmed A Elberry, professor · Faculty of medicine, Beni-Suef university, Beni-Suef, Egypt

  • Hazem S Hussein, MD · Faculty of medicine, Beni-Suef university, Beni-Suef, Egypt

  • Raghda R Sayed, PhD · Faculty of pharmacy, Beni-Suef university, Beni-Suef, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2018-11-30
Completion
2018-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04456712 on ClinicalTrials.gov